Related Experiment Video
Updated: Jun 17, 2026

Promoter Capture Hi-C: High-resolution, Genome-wide Profiling of Promoter Interactions
Published on: June 28, 2018
Identification and characterization of the human SLC5A8 gene promoter
Yu Zhang1, Yong Li Bao, Yin Wu
1National Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun 130024, China.
Abstract:
The human SLC5A8 gene is a tumor suppressor. Its silencing may contribute to the carcinogenesis and progression of various tumors, which makes this gene an attractive molecular marker and a potential target for diagnosis and therapy. Little is known about transcriptional mechanisms controlling SLC5A8 gene expression. To better understand the molecular mechanisms regulating SLC5A8 expression, we characterized the 5'-regulatory region and a part of exon 1. Luciferase reporter assays of deletion mutants of SLC5A8 promoter demonstrated that a 295-bp region is essential for the basal promoter activity of the SLC5A8 gene. Further analysis indicated that the CCAAT boxes and GC boxes were involved in positive regulation of SLC5A8 promoter. Overexpression of two transcription factors, CCAAT/enhancer binding protein beta (C/EBPbeta) and specific transcription factor 1 (Sp1), upregulated the activities of the human SLC5A8 promoter and protein expression, suggesting that both C/EBPbeta and Sp1 transcription factors might have functions in SLC5A8 transcription. Taken together, our results elucidate the mechanism underlying the regulation of SLC5A8 gene transcription and also define a novel regulatory sequence that may be used to increase expression of the SLC5A8 gene in cancer gene therapy.
Insights
The human SLC5A8 gene, a tumor suppressor, has its transcriptional regulation elucidated. Key transcription factors CCAAT/enhancer binding protein beta (C/EBPbeta) and specific transcription factor 1 (Sp1) upregulate SLC5A8 promoter activity for potential cancer therapy.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- The human SLC5A8 gene functions as a tumor suppressor.
- Silencing of SLC5A8 is implicated in carcinogenesis and tumor progression.
- Understanding SLC5A8 transcriptional mechanisms is crucial for its use as a diagnostic and therapeutic target.
Purpose of the Study:
- To investigate the molecular mechanisms regulating SLC5A8 gene expression.
- To characterize the 5'-regulatory region and exon 1 of the SLC5A8 gene.
- To identify key transcription factors involved in SLC5A8 gene regulation.
Main Methods:
- Luciferase reporter assays with deletion mutants of the SLC5A8 promoter.
- Analysis of CCAAT boxes and GC boxes within the promoter region.
- Overexpression studies of transcription factors C/EBPbeta and Sp1.
Main Results:
- A 295-bp region was identified as essential for basal SLC5A8 promoter activity.
- CCAAT boxes and GC boxes positively regulate SLC5A8 promoter activity.
- Overexpression of C/EBPbeta and Sp1 significantly upregulated SLC5A8 promoter and protein expression.
Conclusions:
- The study elucidates the transcriptional regulation mechanism of the human SLC5A8 gene.
- CCAAT/enhancer binding protein beta (C/EBPbeta) and specific transcription factor 1 (Sp1) play key roles in SLC5A8 transcription.
- A novel regulatory sequence was defined, offering potential for increasing SLC5A8 expression in cancer gene therapy.
Related Concept Videos
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Reporter Genes
Commonly used reporter...

